Association between Helicobacter pylori Infection and Pancreatic Cancer Development: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Xiao, Mingjia ^a,b   Wang, Yiming ^b   Gao, Yi ^b  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CAGA PROTEIN;

ARTICLE; ASIA; BACTERIAL STRAIN; CANCER RISK; CARCINOGENESIS; DISEASE ASSOCIATION; EAST ASIA; EUROPE; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; NONHUMAN; NORTH AMERICA; PANCREAS CANCER; SYSTEMATIC REVIEW;

CASE-CONTROL STUDIES; CONTINENTAL POPULATION GROUPS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PANCREATIC NEOPLASMS;

EID: 84884611811     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075559     Document Type: Article

References (59)

1. Hidalgo M, (2010) Pancreatic cancer. N Engl J Med 362: 1605-1617. doi:10.1056/NEJMra0901557. PubMed: 20427809.
2. Hassan MM, Bondy ML, Wolff RA, Abbruzzese JL, Vauthey JN, et al. (2007) Risk factors for pancreatic cancer: case-control study. Am J Gastroenterol 102: 2696-2707. doi:10.1111/j.1572-0241.2007.01510.x. PubMed: 17764494.
3. Lowenfels AB, Maisonneuve P, (2002) Epidemiologic and etiologic factors of pancreatic cancer. Hematol Oncol Clin North Am 16: 1-16. doi:10.1016/S0889-8588(01)00003-X. PubMed: 12063821.
4. Kang R, Tang D, (2012) Autophagy in pancreatic cancer pathogenesis and treatment. Am J Cancer Res 2: 383-396. PubMed: 22860230.
5. Raimondi S, Maisonneuve P, Lowenfels AB, (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6: 699-708. doi:10.1038/nrgastro.2009.177.
6. Wu C, Miao X, Huang L, Che X, Jiang G, et al. (2012) Genome-wide association study identifies five loci associated with susceptibility to pancreatic cancer in Chinese populations. Nat Genet 44: 62-66. PubMed: 22158540.
7. Zhang X, Zhong R, Zhang Z, Yuan J, Liu L, et al. (2011) Interaction of cyclooxygenase-2 promoter polymorphisms with Helicobacter pylori infection and risk of gastric cancer. Mol Carcinog 50: 876-883. doi:10.1002/mc.20784. PubMed: 21538574.
8. Marshall BJ, Warren JR, (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315. PubMed: 6145023.
9. Noto JM, Peek RM Jr, (2012) Helicobacter pylori: an overview. Methods Mol Biol 921: 7-10. doi:10.1007/978-1-62703-005-2_2. PubMed: 23015485.
10. International Agency for Research on Cancer (1994) Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon: International Agency for Research on Cancer. Monogr Eval Carcinog Risks Hum 61: 1-241.
11. Tonkic A, Tonkic M, Lehours P, Mégraud F, (2012) Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 17 (Suppl 1) ():: 1-8. doi:10.1111/j.1523-5378.2011.00892.x. PubMed: 22958148.
12. Hunt RH, Xiao SD, Megraud F, Leon-Barua R, Bazzoli F, et al. (2011) Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointest Liver Dis 20: 299-304.
13. Hansson LE, Engstrand L, Nyrén O, Evans DJ Jr., Lindgren A, et al. (1993) Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology 105: 1098-1103. PubMed: 8405854.
14. Vicari JJ, Peek RM, Falk GW, Goldblum JR, Easley KA, et al. (1998) The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology 115: 50-57. doi:10.1016/S0016-5085(98)70364-6. PubMed: 9649458.
15. Chow WH, Blaser MJ, Blot WJ, Gammon MD, Vaughan TL, et al. (1998) An inverse relation between cagA+ strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 58: 588-590. PubMed: 9485003.
16. Zhou D, Zhang Y, Gong W, Mohamed SO, Ogbomo H, et al. (2011) Are Helicobacter pylori and other Helicobacter species infection associated with human biliary lithiasis? A meta-analysis. PLOS ONE 6: e27390. doi:10.1371/journal.pone.0027390. PubMed: 22087306.
17. Kowalski M, (2001) Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque. J Physiol Pharmacol 52: 3-31.
18. Blaser MJ, Chen Y, Reibman J, (2008) Does Helicobacter pylori protect against asthma and allergy? Gut 57: 561-567. doi:10.1136/gut.2007.133462. PubMed: 18194986.
19. Raderer M, Wrba F, Kornek G, Maca T, Koller DY, et al. (1997) Association between Helicobacter pylori infection and pancreatic cancer. Oncology 55: 16-19. PubMed: 9428370.
20. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, Perez-Perez G, Taylor PR, et al. (2001) Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst 93: 937-941. doi:10.1093/jnci/93.12.937. PubMed: 11416115.
21. Lindkvist B, Johansen D, Borgström A, Manjer J, (2008) A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer 8: 321. doi:10.1186/1471-2407-8-321. PubMed: 18986545.
22. Zhufeng Q, (2012) Preliminary analysis on the association between H. pylori infection and pancreatic cancer. J Guiyang Medical Collège 37: 411-413.
23. Dou YC, Wang JB, (2008) Detection of H. pylori infection in patients with pancreatic cancer and clinical significance. J Jilin University Med Ed 34: 317-319.
24. Gawin A, Wex T, Lawniczak M, Malfertheiner P, Starzynska T, (2012) [Helicobacter pylori infection in pancreatic cancer]. Pol Merkur Lekarski 32: 103-107.
25. Risch HA, (2012) Pancreatic cancer: Helicobacter pylori colonization, N-nitrosamine exposures, and ABO blood group. Mol Carcinog 51: 109-118. doi:10.1002/mc.20826. PubMed: 22162235.
26. Popović N, Nikolić V, Karamarković A, Blagojević Z, Sijacki A, et al. (2010) Prospective evaluation of the prevalence of Helicobacter pylori in abdominal surgery patients. Hepatogastroenterology 57: 167-171. PubMed: 20422896.
27. Kosunen TU, Pukkala E, Sarna S, Seppälä K, Aromaa A, et al. (2011) Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: A cohort study. Int J Cancer 128: 433-439. doi:10.1002/ijc.25337. PubMed: 20309944.
28. Rundle A, Ahsan H, Vineis P, (2012) Better cancer biomarker discovery through better study design. Eur J Clin Invest 42: 1350-1359. doi:10.1111/j.1365-2362.2012.02727.x. PubMed: 22998109.
29. Trikudanathan G, Philip A, Dasanu CA, Baker WL, (2011) Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP 12: 26-31. PubMed: 21206097.
30. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, et al. (2000) Improving the Quality of Reports of Meta-Analyses of Randomised Controlled Trials: The QUOROM Statement. Onkologie 23: 597-602. doi:10.1159/000055014. PubMed: 11441269.
31. Stang A, (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25: 603-605. doi:10.1007/s10654-010-9491-z. PubMed: 20652370.
32. DerSimonian R, Kacker R, (2007) Random-effects model for meta-analysis of clinical trials: an update. Contemp Clin Trials 28: 105-114. doi:10.1016/j.cct.2006.04.004. PubMed: 16807131.
33. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748. PubMed: 13655060.
34. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. doi:10.2307/2533446. PubMed: 7786990.
35. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. doi:10.1136/bmj.315.7109.629. PubMed: 9310563.
36. de Martel C, Llosa AE, Friedman GD, Vogelman JH, Orentreich N, et al. (2008) Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev 17: 1188-1194. doi:10.1158/1055-9965.EPI-08-0185. PubMed: 18483341.
37. Risch HA, Yu H, Lu L, Kidd MS, (2010) ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst 102: 502-505. doi:10.1093/jnci/djq007. PubMed: 20181960.
38. Shimoyama T, Takahashi R, Abe D, Mizuki I, Endo T, et al. (2010) Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol 25 (Suppl 1) ():: S86-S89. doi:10.1111/j.1440-1746.2010.06224.x. PubMed: 20586873.
39. Shiota S, Suzuki R, Yamaoka Y, (2013) The significance of virulence factors in Helicobacter pylori. J Dig Dis 14: 341-349. doi:10.1111/1751-2980.12054. PubMed: 23452293.
40. Huang JQ, Zheng GF, Sumanac K, Irvine EJ, Hunt RH, (2003) Meta-analysis of the relationship between cagA seropositivity and gastric cancer. Gastroenterology 125: 1636-1644. doi:10.1053/j.gastro.2003.08.033. PubMed: 14724815.
41. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D, (2004) Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 159: 252-258. doi:10.1093/aje/kwh039. PubMed: 14742285.
42. Kist M, Strobel S, Kirchner T, Dammann HG, (1999) Impact of ELISA and immunoblot as diagnostic tools one year after eradication of Helicobacter pylori in a multicentre treatment study. FEMS Immunol Med Microbiol 24: 239-242. doi:10.1111/j.1574-695X.1999.tb01289.x. PubMed: 10378427.
43. Lu CY, Kuo CH, Lo YC, Chuang HY, Yang YC, et al. (2005) The best method of detecting prior Helicobacter pylori infection. World J Gastroenterol 11: 5672-5676. PubMed: 16237763.
44. Sörberg M, Engstrand L, Ström M, Jönsson KA, Jörbeck H, et al. (1997) The diagnostic value of enzyme immunoassay and immunoblot in monitoring eradication of Helicobacter pylori. Scand J Infect Dis 29: 147-151. doi:10.3109/00365549709035875. PubMed: 9181650.
45. Lu H, Yamaoka Y, Graham DY, (2005) Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol 21: 653-659. doi:10.1097/01.mog.0000181711.04529.d5. PubMed: 16220040.
46. Boncristiano M, Paccani SR, Barone S, Ulivieri C, Patrussi L, et al. (2003) The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med 198: 1887-1897. doi:10.1084/jem.20030621. PubMed: 14676300.
47. Kim JM, Kim JS, Lee JY, Kim YJ, Youn HJ, et al. (2007) Vacuolating cytotoxin in Helicobacter pylori water-soluble proteins upregulates chemokine expression in human eosinophils via Ca2+ influx, mitochondrial reactive oxygen intermediates, and NF-kappaB activation. Infect Immun 75: 3373-3381. doi:10.1128/IAI.01940-06. PubMed: 17452475.
48. Goh KL, Chan WK, Shiota S, Yamaoka Y, (2011) Epidemiology of Helicobacter pylori infection and public health implications. Helicobacter 16 (Suppl 1) ():: 1-9. doi:10.1111/j.1523-5378.2011.00874.x. PubMed: 21896079.
49. Brown LM, (2000) Helicobacter pylori: epidemiology and routes of transmission. Epidemiol Rev 22: 283-297. doi:10.1093/oxfordjournals.epirev.a018040. PubMed: 11218379.
50. Nilsson HO, Stenram U, Ihse I, Wadstrom T, (2006) Helicobacter species ribosomal DNA in the pancreas, stomach and duodenum of pancreatic cancer patients. World J Gastroenterol 12: 3038-3043. PubMed: 16718784.
51. Risch HA, (2003) Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J Natl Cancer Inst 95: 948-960. doi:10.1093/jnci/95.13.948. PubMed: 12837831.
52. Blaser MJ, (1992) Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 102: 720-727. PubMed: 1732141.
53. Houben GM, Stockbrügger RW, (1995) Bacteria in the aetio-pathogenesis of gastric cancer: a review. Scand J Gastroenterol Suppl 212: 13-18. PubMed: 8578226.
54. Kokkinakis DM, Reddy MK, Norgle JR, Baskaran K, (1993) Metabolism and activation of pancreas specific nitrosamines by pancreatic ductal cells in culture. Carcinogenesis 14: 1705-1709. doi:10.1093/carcin/14.8.1705. PubMed: 8353856.
55. Fox JG, Dewhirst FE, Shen Z, Feng Y, Taylor NS, et al. (1998) Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 114: 755-763. doi:10.1016/S0016-5085(98)83089-8. PubMed: 9516396.
56. Chey WD, Fendrick AM, (2001) Noninvasive Helicobacter pylori testing for the "test-and-treat" strategy: a decision analysis to assess the effect of past infection on test choice. Arch Intern Med 161: 2129-2132. doi:10.1001/archinte.161.17.2129. PubMed: 11570943.
57. Ladabaum U, Chey WD, Scheiman JM, Fendrick AM, (2002) Reappraisal of non-invasive management strategies for uninvestigated dyspepsia: a cost-minimization analysis. Aliment Pharmacol Ther 16: 1491-1501. doi:10.1046/j.1365-2036.2002.01306.x. PubMed: 12182749.
58. Aschebrook-Kilfoy B, Cross AJ, Stolzenberg-Solomon RZ, Schatzkin A, Hollenbeck AR, et al. (2011) Pancreatic cancer and exposure to dietary nitrate and nitrite in the NIH-AARP Diet and Health Study. Am J Epidemiol 174: 305-315. doi:10.1093/aje/kwr092. PubMed: 21685410.
59. Larsson SC, Wolk A, (2012) Red and processed meat consumption and risk of pancreatic cancer: meta-analysis of prospective studies. Br J Cancer 106: 603-607. doi:10.1038/bjc.2011.585. PubMed: 22240790.